Literature DB >> 16572107

Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample.

C S Fox1, M G Larson, S-J Hwang, E P Leip, N Rifai, D Levy, E J Benjamin, J M Murabito, J B Meigs, R S Vasan.   

Abstract

Experimental models suggest that increased aldosterone and sodium intake are associated with renovascular damage and resultant proteinuria. We hypothesized that serum aldosterone and urinary sodium would be associated with urinary albumin excretion, an indicator of kidney damage. We evaluated 2700 participants (53% women, mean age 58 years) from the Framingham Offspring Study who attended a routine examination between 1995 and 1998, who were free of heart failure and renal failure, and underwent testing for serum aldosterone, spot urinary sodium, and urinary albumin excretion (urine albumin/creatinine ratio, UACR), the latter two indexed to urinary creatinine. Stepwise multivariable linear regression was used to evaluate the relations between UACR with urinary sodium index and serum aldosterone. In multivariable regression, log urinary sodium index was associated positively with log-UACR (P<0.0001). UACR levels in the fourth and fifth quintiles of urinary sodium index were 24% (95% confidence interval (CI) 3-49%), and twofold higher (95% CI 72-150%), respectively, relative to the lowest quintile (P-value for trend across quintiles <0.001). In multivariable models, log-transformed aldosterone was not related to log-UACR. The top quintile of serum aldosterone levels was associated with a 21% higher (95% 1-44%) UACR levels relative to the lowest quintile. Urinary albumin excretion was strongly and positively associated in a continuous fashion with urinary sodium excretion, whereas a weaker nonlinear positive relation with serum aldosterone was noted. Our cross-sectional observations raise the possibility that dietary salt intake may be associated with early renovascular damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572107     DOI: 10.1038/sj.ki.5000378

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

1.  Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats.

Authors:  Wei Liang; Cheng Chen; Jing Shi; Zhilong Ren; Fengqi Hu; Harry van Goor; Pravin C Singhal; Guohua Ding
Journal:  Nephrol Dial Transplant       Date:  2010-08-20       Impact factor: 5.992

2.  Aldosterone receptor antagonists: effective but often forgotten.

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

Review 3.  Resistant hypertension and aldosteronism.

Authors:  Eduardo Pimenta; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2007-11       Impact factor: 5.369

Review 4.  Aldosterone and cardiovascular risk.

Authors:  Bruno Vogt; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

5.  Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Kristal J Aaron; Ruth C Campbell; Suzanne E Judd; Paul W Sanders; Paul Muntner
Journal:  Am J Clin Nutr       Date:  2011-08-31       Impact factor: 7.045

6.  The role of aldosteronism in causing obesity-related cardiovascular risk.

Authors:  David A Calhoun; Kumar Sharma
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

Review 7.  Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.

Authors:  Daniel Glicklich; William H Frishman
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

Review 8.  Resistant hypertension and hyperaldosteronism.

Authors:  Carolina C Gonzaga; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

9.  Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study.

Authors:  Akiko Fukui; Masaru Nakayama; Shigeru Tanaka; Yuta Matsukuma; Ryota Yoshitomi; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin Exp Nephrol       Date:  2020-08-29       Impact factor: 2.801

10.  Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study.

Authors:  Nancy R Cook; Eva Obarzanek; Jeffrey A Cutler; Julie E Buring; Kathryn M Rexrode; Shiriki K Kumanyika; Lawrence J Appel; Paul K Whelton
Journal:  Arch Intern Med       Date:  2009-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.